Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Celularity Inc Director's Dealing 2022

Nov 19, 2022

34506_dirs_2022-11-18_616aa17a-43ec-4a1b-a953-83f7c7b11917.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2021-11-16

Reporting Person: Jones Anne (Chief Business Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-16 Class A Common Stock A 25000 $0.00 Acquired 52888 Direct
2022-11-16 Class A Common Stock F 3734 $1.89 Disposed 49154 Direct

Footnotes

F1: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date so that vested in full on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.

F2: Represents 52,888 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.

F3: Represents shares withheld by the Issuer to cover withholding taxes associated with the vesting and settlement of RSUs granted under the 2021 Plan and does not represent a sale.

F4: Includes 40,388 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.